• English

    Google Translate Disclaimer

    The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

    DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

    DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

    The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.

    State Releases 3rd Quarter Fatal Overdose Data

    Fentanyl continues to be most prevalent drug found in opioid-related overdose deaths; heroin-related deaths show slight decline

    Baltimore, MD (January 26, 2018) – The Maryland Department of Health today released data for unintentional fatal overdoses through the third quarter of 2017. During this nine-month period, which encompasses January through September of 2017, there were 1,501 opioid-related deaths in the state, including 1,173 fentanyl-related deaths. The report can be found here. Past reports can be found on this page.
    The largest increases in overdose deaths continue to be related to fentanyl and from cocaine use combined with opioids, however there has been a slight decline in the overall number of heroin-related and prescription opioid-related deaths when comparing third quarter data for 2016 and 2017.  
    “The Department issued a warning against fentanyl in 2016 and I want to reiterate the dangers of it and other synthetic drugs, which are the leading cause of overdose deaths in Maryland,” said Secretary Robert R. Neall. “We implore Marylanders who are grappling with substance use disorders and are taking illicit substances to seek treatment immediately, and for others to take advantage of the standing order for naloxone by learning how to administer it and carry it with them.”
    For the second quarter in a row, the largest increases in overdose deaths continue to be fentanyl-related and from cocaine use combined with opioids. Over the first three quarters of the year, the percentage of opioid-related deaths involving fentanyl increased from 56 percent of all opioid-related deaths in 2016 to 78 percent in 2017. Throughout 2016, the number of heroin-related deaths exceeded the number of fentanyl-related deaths; this trend has reversed in 2017, with fentanyl-related deaths outpacing heroin-related deaths in each quarter. More than two-thirds of all overdose deaths through September 2017 involved fentanyl.
    The number of fatal cocaine overdoses increased 47 percent in the first nine months of 2017, compared to the same time in 2016. Much of this increase is due to fentanyl being combined with cocaine, often unbeknownst to the user. Fentanyl was present in 50 percent of fatal cocaine overdoses in 2016 and 68 percent in 2017, for the period of January through September.
    The total number of heroin-related and prescription opioid-related deaths, which were flat in a comparison between the second quarter data for 2016 and 2017, have started to show a slight drop. Through the third quarter of 2017, the number of heroin-related deaths fell by 56 when compared to the first three quarters of 2016. Prescription opioid-related deaths fell by 11 during the same period.
    Maryland has expanded access to naloxone, a life-saving drug that reverses opioid drug overdoses. On June 1, 2017, Health’s Public Health deputy secretary, Dr. Howard Haft, issued a standing order that allows pharmacies to dispense naloxone to individuals who may be at risk of an overdose or anyone who may be able to help someone who overdoses. This action is authorized through legislation signed by Governor Larry Hogan. Naloxone safely and effectively reverses an overdose and has a low risk for adverse effects. This simplifies the previous process where it could be dispensed only to those trained and certified under the Maryland Overdose Response Program. Pharmacies play an important role in providing access to naloxone and counseling on how to recognize and respond to an opioid overdose. Fentanyl and carfentanil may require multiple doses of naloxone to be administered to help victims overdosing on those substances.
    'We continue to push resolve, momentum, and coordination, as well as a balanced approach of prevention, enforcement, and improving access to treatment,' said Clay Stamp, executive director of Maryland’s Opioid Operational Command Center. 'Through our statewide partnerships and collaboration, we are committed to educating our citizens about the grave dangers of opioid addiction, while connecting those in need of treatment to the resources they need to get better.'
    Fighting the heroin and opioid epidemic in Maryland has been a top priority of the Hogan-Rutherford administration. The Department of Health, in partnership with the Opioid Operational Command Center and other state agencies, continues to collaborate with federal, state, and local partners to fight to reduce the number of overdoses and resulting fatalities in a multitude of ways.
    Marylanders can find treatment resources at MdDestinationRecovery.org, BeforeItsTooLateMD.org and the Maryland Crisis Hotline, 1-800-422-0009.
    Marylanders who need help finding substance related disorder treatment resources should visit MdDestinationRecovery.org, BeforeItsTooLateMD.org, or call the Maryland Crisis Hotline, which provides 24/7 support, at 1-800-422-0009. If you know someone who could use treatment for substance related disorders, treatment facilities can be found  by location and program characteristics through our Website here.